Genomic landscape of human allele-specific DNA methylation by Fang,  F. et al.
Genomic landscape of human allele-specific
DNA methylation
Fang Fanga, Emily Hodgesb, Antoine Molarob, Matthew Deana, Gregory J. Hannonb, and Andrew D. Smitha,1
aMolecular and Computational Biology, Department of Biological Sciences, University of Southern California, Los Angeles, California; and
bHoward Hughes Medical Institute, Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724
Edited by Wing Hung Wong, Stanford University, Stanford, CA, and approved March 8, 2012 (received for review January 24, 2012)
DNA methylation mediates imprinted gene expression by passing
an epigenomic state across generations and differentially marking
specific regulatory regions on maternal and paternal alleles. Im-
printing has been tied to the evolution of the placenta in mammals
and defects of imprinting have been associated with human dis-
eases. Although recent advances in genome sequencing have revo-
lutionized the study of DNA methylation, existing methylome data
remain largely untapped in the study of imprinting. We present a
statistical model to describe allele-specific methylation (ASM) in
data from high-throughput short-read bisulfite sequencing. Simula-
tion results indicate technical specifications of existing methylome
data, such as read length and coverage, are sufficient for full-
genome ASM profiling based on our model. We used our model to
analyze methylomes for a diverse set of human cell types, including
cultured and uncultured differentiated cells, embryonic stem cells
and induced pluripotent stem cells. Regions of ASM identified most
consistently across methylomes are tightly connected with known
imprinted genes and precisely delineate the boundaries of several
known imprinting control regions. Predicted regions of ASM com-
mon to multiple cell types frequently mark noncoding RNA promo-
ters and represent promising starting points for targeted validation.
More generally, our model provides the analytical complement to
cutting-edge experimental technologies for surveying ASM in spe-
cific cell types and across species.
Genomic imprinting refers to genes that are preferentially ex-pressed from either the maternal or paternal allele without
genotype dependence (1). In mammals, such parent-of-origin gene
expression is believed to have evolved along with the placenta, ser-
ving to mediate resource distribution between a mother and her
offspring (2, 3), though other theories have been proposed (4–6).
The connection between imprinting and DNAmethylation was
uncovered shortly after the first identification of imprinted genes
in mammals (7). Imprinted gene expression, in all known cases, is
regulated by allele-specific methylation (ASM) of some cis-acting
regulatory regions. We use the term allelically methylated region
(AMR) in reference to any genomic interval of ASM, whether or
not it is associated with imprinted regulation. Typically, an entire
imprinted locus is organized as a cluster and regulated by an
imprinting control region (ICR) and several other AMRs. The
allelic methylation patterns of ICRs are set during gametogenesis
and stably maintained throughout somatic development in the
offspring (8), irrespective of gene expression levels. The remain-
ing AMRs may be established after fertilization (9), possibly un-
der the control of nearby ICRs or other epigenetic signals.
The identification of imprinted genes and a detailed under-
standing of their regulation has become increasingly important,
along with the realization that aberrant genomic imprinting
contributes to several complex diseases (10). Much effort has
been directed toward locating imprinted genes using expression
screen-based approaches (11, 12). One limitation of such ap-
proaches is that many imprinted genes may only show allele-
specific expressions in particular tissues at appropriate develop-
mental stages (13). ASM screen-based approaches might over-
come the effect of temporal and spatial expression patterns
because the ICRs are expected to exist through developmental
stages preceding the context in which they become active. Such
methods have been successfully applied to identify unique im-
printed genes (14–17).
Advances in DNA sequencing technology have been leveraged
for high-throughput identification of imprinted genes. The “BS-
seq” technology couples bisulfite treatment with high-throughput
short-read sequencing, and has enabled genome-wide profiling of
DNA methylation in mammalian genomes at single-CpG (cyto-
sine guanine dinucleotide) resolution (18). Li et al. (19) produced
a methylome from peripheral blood of a single individual and
recognized the potential of using such data to profile ASM. They
employed a method based on associating heterozygous SNPs
with differential methylation, and identified hundreds of ASM
regions. Methods such as this, however, must be applied to data
from a single individual and for which matching genotypic data
are available. There are two shortcomings of approaches that
depend on genotype. First, they can be confounded by ASM that
is associated with genotype, but which may not have any regula-
tory effect. The amount of ASM typically associated with geno-
type is not well understood, but recent reports suggest it is
significant (20). More importantly, because imprinted methyla-
tion is not necessarily associated with genotypic variation, these
methods will be inherently blind to some portion of ASM.
We present a probabilistic model to describe ASM based on
data from BS-seq experiments. Our model is independent of
genotype, and therefore has broad applicability to identify ASM
in the context of imprinting. In essence, our model describes the
degree to which methylation states in reads appear to reflect
two distinct patterns, each pattern representing roughly half the
data. We validated our method using semisimulated data in which
methylation states were simulated within actual reads from BS-
seq experiments. Our results indicate that technical characteris-
tics of existing public methylomes (i.e., read length and coverage)
are sufficient to accurately identify AMRs. By applying our model
to 22 human methylomes, emphasizing those from uncultured
cells, we identified a set of candidate AMRs involved in im-
printed gene regulation. Candidates consistently identified across
methylomes display remarkable concordance with known im-
printed genes and allow boundaries of known AMRs to be pre-
cisely defined. Many candidates not associated with known
imprinted genes mark the promoters of long noncoding RNAs
(lncRNAs) and are also supported by similar analyses at ortho-
logous regions in chimp; these provide a starting point for iden-
tifying additional imprinted genes, ICRs, and possibly imprinted
clusters. Our model, therefore, is an essential analytical comple-
ment to recently emerged experimental methods for understand-
ing the role of DNA methylation in genomic imprinting.
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Modeling Allele-Specific Methylation in BS-Seq Data
We begin this section with a verbal description of our question
and the main issues that are addressed by our model. We assume
any read has been sequenced after bisulfite treatment and
mapped uniquely to the reference genome. Because we are inter-
ested in mammalian methylation, we restrict our attention to
CpG sites both in the genome and in the reads. Reads not map-
ping over a CpG are ignored. Our goal is to identify intervals of
the genome where it appears that the two alleles have different
methylation patterns—typically, in such a case, one allele will be
highly methylated and the other not. There are two kinds of im-
portant information our model must capture: (i) The set of reads
mapping into the interval should appear to represent two distinct
methylation patterns, and (ii) the subsets of reads corresponding
to those two patterns should be in roughly equal proportions be-
cause the alleles themselves are present in equal proportions.
One can consider a methylation pattern as analogous to a hap-
lotype, but with a strong stochastic component. Therefore, reads
that contain only a single CpG will provide us with relatively little
information, and we would like reads to cover as many CpGs as
possible. We can then ask whether neighboring CpG sites on the
same read tend to share methylation states, and whether other
reads cover the same CpG sites but with the alternative shared
methylation state. Our approach is to apply a single-allele model
to the data, then apply an allele-specific model, and to compare
the fit for these models to determine if the data support ASM.
Modeling Site-Specific DNA Methylation in a Single Allele.We associ-
ate each CpG with a single parameter indicating the probability
that the CpG is methylated in the cells of interest. For a genomic
interval containing n CpGs, the single-allele model is Θ ¼
ðθ1;…; θnÞ. Given a set of reads R, the likelihood in the single-
allele model within the interval is
L1ðΘjRÞ ¼ PrðRjΘÞ ∝
Yn
i¼1
θmðR;iÞi ð1 − θiÞuðR;iÞ; [1]
where mðR; iÞ and uðR; iÞ give the numbers of methylated and
unmethylated observations from reads mapping over the ith
CpG. Estimates for each θi are obtained assuming a binomial dis-
tribution for methylation states mðR; iÞ.
Modeling Regions of Allele-Specific Methylation. Within regions of
ASM, we use a two-allele model that associates two distinct
methylation probabilities with each CpG. Assuming there are
n CpGs in the genomic interval, the two-allele model has the
structure Θ ¼ fðθ11; θ12Þ;…; ðθn1; θn2Þg, with θi1 and θi2 repre-
senting the methylation probabilities at the ith CpG on allele
one and allele two, respectively. Under this model, reads mapping
over the same genomic CpG may have different probabilities of
methylation for their CpGs depending on the allele from which
they originate. The allele of origin for any read is missing data,
and for a given set R of reads we express this missing data as the
partition γ ¼ fγ1; γ2g defined by R ¼ γ1 ∪ γ2, where jRj ¼ jγ1jþ
jγ2j. For any r ∈ R, if r ∈ γj, we say that r originates from allele j.
Because we are modeling alleles in the context of data from a
diploid cell population, the probability that any read originates
from a given allele is 0.5. Thus the likelihood is
L2ðΘjR; γÞ ¼ PrðRjγ; ΘÞPrðγÞ [2]
because the partition γ is independent of Θ. The probability PrðγÞ
is effectively a prior on the read partition assuming
jγ1j ∼ binomialðjγ1j þ jγ2j; 0.5Þ
because each allele is present with equal frequency. Therefore,
L2ðΘjR; γÞ ¼
 jRj
jγ1j

0.5 jRj
Yn
i¼1
Y2
j¼1
θ
mðγj ;iÞ
ij ð1 − θijÞuðγj;iÞ; [3]
where the m and u are as defined for Eq. 1. Because the allele of
origin for each read is missing data, we fit the two-allele model
using expectation maximization (21), obtaining expectations on
membership in γ1 and γ2. Details are provided in SI Text.
Identifying Intervals of Allele-Specific Methylation.We use Bayesian
information criterion (BIC) (22) as a model selection criterion
in determining whether a fixed interval is best described using
a single-allele [Eq. 1] or two-allele [Eq. 2] model. A single-allele
model has one parameter for each of the n CpGs, and the number
of observations is equal to jRj:
BICðsingleÞ ¼ n ln jRj − 2 lnL1ðΘjRÞ: [4]
For the two-allele model, there are two parameters for each CpG:
BICðpairÞ ¼ 2n ln jRj − 2 lnL2ðΘjR; γÞ: [5]
An interval is identified as having allele-specific methylation if
and only if BICðpairÞ < BICðsingleÞ.
We identify regions of ASM genome-wide by using a fixed-
width sliding window (i.e., fixed number of CpG sites) and deter-
mining for each whether the single- or two-allele model better
describes the data. Results we present are based on a sliding
window of 10 CpGs, and issues related to selecting a window size
are discussed in the SI Text. Intervals in close proximity are
merged, and we also excluded intervals overlapping large subunit
ribosomal RNA (LSU rRNA) genes from our final analyses be-
cause we suspected problems with their assembly in the reference
genome (see SI Text).
Semisimulated Allele-Specific Methylation Data
We conducted simulations to evaluate how the performance of
our model relates to several critical parameters of the underlying
dataset. To reflect performance characteristics on real datasets,
we used a strategy called “semisimulated” data. The locations of
mapped reads were taken from real data, as were the locations of
CpGs within reads and the underlying reference genome. The
methylation states inside those reads were determined according
to randomly generated allele-specific or single-allele methylation
profiles. Briefly, within a region designated as an AMR, we ran-
domly generated two methylation profiles by sampling individual
CpG methylation levels as βeta variants skewed toward 0 or 1.
Then we assigned each read with equal probability to one of the
two alleles, and the methylation states of the CpGs within the
read were sampled according to probabilities given by the methy-
lation profile corresponding to that allele. A full description of
this procedure is provided in the SI Text.
With current methylomes from BS-seq, we expected the varia-
tion in coverage along chromosomes to be a critical factor for the
performance of our model. In addition, the variation in inter-
CpG distance may prevent our method from capturing ASM
in regions of low CpG density for a fixed read length. We exam-
ined how well our method could identify ASM in a given genomic
interval by manipulating three independent variables:
• Mean coverages were {5×, 10×, 15×}, corresponding to cur-
rent methylomes from BS-seq.
• Read lengths were {50, 100, 150} bases corresponding roughly
with current short-read sequencing technologies.
• CpG density distributions took three different settings: CpG is-
lands (CGIs) defined as in ref. 23, non-CGI promoters defined
as 1 kb upstream of transcription start site (TSS) in National
Center for Biotechnology Information reference sequences but
not CGIs, and randomly sampled genomic background with
CpG density (observed/expected) between 0.2 and 0.4.
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Details concerning the number of simulated datasets for each
parameter combination can be found in the SI Text.
Specificity was generally very high (approximately 99%) for all
simulation parameter combinations, reflecting our conservative
model selection criterion (Eqs. 4 and 5). In contrast, sensitivity
showed greater dependence on properties of the datasets. Sensi-
tivity was higher for regions of higher CpG density, as expected
because our model depends on the relationships between CpG
states inside a read. As shown in Fig. 1, inside CGIs sensitivity
reached above 95% for all read lengths when the mean coverage
was above 10×. Sensitivity reached approximately 70% for inter-
genic regions but required both 10× coverage and read length
100, which compensates for the decrease in CpG density. As
expected, greater coverage and read length improved accuracy,
and the effect of read length is equivalent to that of CpG density.
These results indicate that methylomes with read lengths around
100 bp and mean coverage above 10× appear sufficient for our
model to accurately identify ASM. These criteria are met by most
existing methylomes from BS-seq experiments.
Properties of the Methylomes Analyzed
We analyzed 22 publicly available methylomes, including five un-
cultured primary cell types, eight cultured differentiated cell
lines, four embryonic stem cells (ESCs), and five induced pluri-
potent stem cells (iPSCs) from following studies. Additional de-
tails about each of the methylomes can be found in Dataset S1.
Hodges et al. (24) produced four uncultured methylomes from
blood cells: hematopoietic stem and progenitor cells (HSPC),
B cells, neutrophils, and CD133+ cord blood cells. Because the first
three samples were pooled from six unrelated individuals, ASM
caused by genetic variants should not be apparent due to the effect
of pooling. The last sample was generated from one individual.
Li et al. (19) produced the other uncultured methylome from per-
ipheral blood mononuclear cells (PBMC) of one individual.
The study of Laurent et al. (25) produced three methylomes:
foreskin fibroblasts, H9 ESCs, and fibroblasts derived from H9
ESCs. Lister et al. (18) produced methylomes for IMR90 cells
and H1 ESCs, two replicates each which we treat as distinct
methylomes. In a separate study, Lister et al. (26) produced
methylomes for 10 cell types. Included among these were H9
ESCs, adipose-derived stem cells (ADS), adipocytes derived from
ADS cells (ADS Adipose) and foreskin fibroblasts (FF). Induced
pluripotent stem cells derived from ADS, IMR90, and FF cells
were also profiled, with FF iPSCs taken at three different times,
the last of which were also profiled after being differentiated in
the presence of bone morphogenic protein 4 (BMP4).
Allele-Specific Methylation on the X Chromosome
Though not a form of imprinting, dosage compensation is asso-
ciated with ASMdifferentially marking one chromosome X (chrX)
in female somatic cells (27). In contrast, only a single allele from
chrX is represented in male methylome data. Comparing the re-
sults of our analyses between male and female X chromosomes
therefore provides a measure of specificity: AMRs identified on
chrX in males are likely false-positives. In total, 12 of the analyzed
methylomes are female. Although coverage on chrX in males is
reduced by half, three male methylomes approached 10× coverage
on chrX (H1 ESC rep 2, FF, and FF iPSC BMP4; refs. 18 and 26).
The locations of identified AMRs on chrX are presented in
Fig. 2. The fraction of AMRs from chrX in female methylomes
ranges from 15% to 36% with a mean of 24%. For the three male
methylomes tested, the fraction is in the range of 1% to 2%. These
results further support our conclusion from simulations that spe-
cificity is high in our AMR prediction. X chromosome inactivation
is regulated via the X-inactive specific transcript (XIST) gene, a
lncRNA with random allele-specific expression in female somatic
cells. Our analyses identified an AMR at the XIST promoter in
each female differentiated methylome (Fig. S1), but not in any
of the ESCs, iPSCs, or male methylomes as expected (28).
Genome-Wide AMR Identification Predicts Imprinted Genes
The full set of identified AMRs for each of the 22 methylomes is
presented in Dataset S1. We emphasized the uncultured blood
methylomes in compiling sets of high-confidence AMRs, and
generally use the remaining methylomes to provide additional
supporting evidence. We found 579 autosomal AMRs that are
common to at least three of the five uncultured methylomes
(HSPCs, B cells, neutrophils, CD133+ cord blood, and PBMCs),
247 common to at least four out of five, and 81 shared across all
five. Table 1 presents the 39 AMRs common to all five uncultured
methylomes and that are proximal to promoters (4 kb of a
University of California Santa Cruz KnownGene TSS). Among
these, 18 overlap a known imprinted gene and 20 mark a lncRNA
promoter. The high concordance between our prediction and
known imprinted genes further validates our model and provides
strong support for the remaining predictions as candidate im-
printed genes. The regulatory activity of lncRNAs has been ob-
served for most imprinted clusters (29), and the frequent overlap
of identified AMRs and lncRNA promoters suggests these might
have similar activity (30). We also identified AMRs in low-cover-
age chimp blood cell data from the study of Hodges et al. (24),
adding additional evidence to several of our predictions.
We computed the methylation level in sperm at each of the
identified AMRs using data from a previous study (31). Among
the 579 autosomal AMRs common to three out of five uncultured
methylomes, 146 were methylated (>50%) in sperm. As indicated
in Table 1, among the 39 predicted AMRs common across all un-
cultured cell types, only three are methylated in sperm. Among
these is the H19 ICR, which is well known to be methylated on
the paternal allele (32). If we use the methylation level in sperm
as an indicator of methylation on the paternal allele, these results
point to an asymmetry in the paternal and maternal mechanisms
of imprinting DNA methylation.
One of the central questions related to the use of iPSCs, in
research or therapeutically, is the degree to which they resemble
true ESCs. The landmark study of Lister et al. demonstrated sig-
nificant reprogramming variability between iPSCs (26). Evidence
from cloning studies suggests that imprinting might be especially
difficult to reprogram (33). We assembled the union of all iden-
tified AMRs in all methylomes. For each of these AMRs, we
computed average methylation in each methylome. We then clus-
tered the methylomes hierarchically according to correlation of
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Fig. 1. Sensitivity of AMR identification based on semisimulated data. Coverages of 5, 10, and 15×, and read lengths of 50, 100, and 150 bp were used. CpG
densities were controlled by simulating within (A) CGIs, (B) non-CGI promoter regions, and (C) non-CGI intergenic regions.
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methylation levels through these intervals (Fig. S2). The iPSCs
correlated better with ESCs than with the somatic cells from
which they are derived, suggesting that ASM has in general been
successfully reprogrammed in these iPSCs.
However, we found several examples where the iPSCs appear
to diverge from the ESCs in terms of ASM (Fig. S3). An AMR
was identified at the GNAS-1 promoter in 18 of the methylomes,
but this interval was hypomethylated in the ADS iPSCs. Similarly,
for the AMR identified at the 3′ promoter of ZNF331 gene, the
ADS iPSCs are methylated at 50% and resemble differentiated
cells more closely than ESCs or other iPSCs, suggesting failed
reprogramming of ADS iPSCs at these locations. It has been pro-
posed that a single imprinted cluster might be sufficient to diag-
nose iPSC reprogramming in mouse (34). The diversity of ASM
we observe between iPSCs and even between ESC lines suggests
such diagnosis will be more complex in human.
Analysis of Known Imprinting Control Regions
There are approximately 65 human genes currently validated
as imprinted and these reside in 32 imprinted clusters (see
Dataset S1). We asked for what proportion of these clusters do
we identify an AMR shared between cells, and do these shared
AMRs coincide with experimentally validated AMRs? As can
be seen from Table 2, 24 of the clusters contain validated AMRs,
and in 21 of those cases we correctly identify a known AMR com-
mon to four out of five uncultured cells. For the IGF2R and
INPP5F clusters, we only identified AMRs shared between two
and three of the uncultured cells, respectively. The AMPD3 gene
has no validated AMR to our knowledge. Our algorithm finds an
AMR shared across all 22 methylomes, indicating a likely candi-
date for validation. To our knowledge, no AMRs have yet been
identified for the remaining clusters, and our algorithm fails to
predict any AMRs that are shared between methylomes.
Knowledge of the location of true AMRs around several
of these imprinted genes allowed us to apply a more intensive
analysis to examine them with greater sensitivity and precision.
We designed a dynamic programming algorithm to optimize the
locations of AMR boundaries by evaluating each possible AMR
size rather than joining overlapping sliding windows. This algo-
rithm uses a scoring function based on the likelihoods of Eqs. 1
and 2 but remains too computationally demanding for genome-
wide application (details are provided in the SI Text). We refer to
AMRs identified with this algorithm as “refined” AMRs.
The imprinted cluster on chr14 consists of seven genes con-
trolled by the maternally expressed lncRNA MEG3. The region
harbors an AMR at the MEG3 promoter, and another intergenic
AMR approximately 15 kb upstream of the MEG3 TSS, both
paternally methylated with the upstream AMR shown to act as
an ICR (35). Our genome-wide scan found the MEG3 promoter
AMR in 11∕13 differentiated cells. The boundaries of refined
AMRs were identified in each uncultured methylome at nearly
the exact same location, covering an interval that is hypomethy-
lated in sperm (Fig. S4). A refined AMR was identified in each
uncultured methylome precisely at the known ICR location,
which is methylated in sperm. Interestingly, each of the ESC/iPSC
methylomes shows full methylation through the ICR, suggesting
possible imprinting defects in these cells.
Imprinted expression in the GNAS locus is highly complex,
with maternally, paternally, and biallelically expressed transcripts
sharing sets of exons (36). This locus includes four AMRs at
alternative promoters (NESP55, GNAS-AS1, XLαs, Exon A/B)
Table 1. AMRs common to all uncultured cells that overlap gene
promoters
Gene symbols NC CGI Sp ESC iPSC Tot Chimp
* GNAS,… Y Y 4 5 22 3
* GNAS-AS1,… Y Y 4 5 22 3
* MESTIT1/MEST,… Y Y 4 5 22 3
* SGCE,PEG10 Y 4 5 22 3
NHP2L1 Y 4 5 22 3
* ZNF597,NAA60 Y 4 5 22 3
* SNRPN,SNURF Y 4 5 22 2
* AMPD3,… Y 4 5 22 0
PMF1-BGLAP Y 4 5 22 0
LOC554226,… Y Y 4 5 22 0
UNC45B 4 5 22 0
LINC00273 Y Y 4 5 22 0
* NAP1L5 4 5 21 3
KCNQ1OT1 Y Y 3 5 21 0
LOC284801,… Y Y 4 4 21 0
* PSIMCT1 Y Y 2 5 20 0
* H19,… Y Y Y 2 5 20 0
TRAPPC9 Y 3 4 20 0
CR590796 Y 4 3 20 0
* DIRAS3 Y 2 5 19 2
AX748049 2 5 19 2
BC028329 Y 3 4 19 2
ZNF718,ZNF595 Y 3 5 19 0
BC023516 Y Y 3 5 18 3
LOC100130522 Y Y 2 4 18 3
* FANK1 Y 2 5 18 0
* GNAS Y Y 2 3 18 0
VTRNA2-1 Y Y 3 4 17 3
MTRNR2L3 Y 4 1 15 0
* BLCAP,NNAT Y 2 2 14 2
LOC728024 Y 0 3 14 2
RPS2P32 Y Y 0 3 14 2
* ZIM2,PEG3,… Y Y 1 0 12 0
* MEG3 Y 0 0 11 3
LOC100132167 Y 1 0 11 0
* HOXA6,HOXA5,… Y Y 0 0 8 2
KIAA0934,DIP2C Y Y 0 0 8 2
LOC440570,… Y 0 0 5 3
LOC100335030 Y 0 0 5 1
Columns indicate whether the gene is noncoding (NC), the AMR overlaps a
CGI promoter (CGI), or is hypermethylated in sperm (Sp). Counts indicate the
number of ESC, iPSC, total human methylomes, and chimp methylomes in
which the AMR is found. Ellipsis indicate additional gene names can be
found in Dataset S1. Asterisk * indicates known imprinted gene.
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Fig. 2. Locations of AMRs identified on chrX. All female data (pink) was included. Only male methylomes (blue) with sufficient coverage on chrX are shown
because these have coverage reduced by 50% compared with autosomes. Numbers in brackets indicate references for data sources. See text and Dataset S1 for
information about methylomes.
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(37). We identified refined AMRs at these locations in all uncul-
tured methylomes (Fig. 3). Between different methylomes,
boundaries of refined AMRs fluctuated by fewer than 10 CpGs
and frequently were identified at identical locations. In each case,
two separate refined AMRs were identified at the GNAS-AS1
and XLαs promoters. The consistent location of the refined
AMR boundary between the GNAS-A/B and GNAS-1 TSS,
which coincides with the center of a CGI, suggests a strict parti-
tion of regulatory sequence between these two transcripts.
The LTR-derived PEG10 and the adjacent SGCE are part
of an imprinted gene cluster on chr7 sharing complete synteny
with imprinted orthologs in mouse (38). PEG10 and SGCE are
separated by less than 100 bp, are divergently transcribed, and
have a single CGI overlapping both TSS. Our analyses revealed
an AMR at their shared promoter in all 22 methylomes, with a
positional bias in the direction of PEG10. As can be seen from
Fig. 3, the refined AMRs in uncultured methylomes have iden-
tical boundaries precisely between the PEG10 and SGCE TSS at
the center of a CGI similar to the GNAS-A/B case described
above. Each refined AMR is fully contained inside the body of
PEG10, consistent with the LTR origin of PEG10, which implies
that PEG10 carries internal regulatory elements. This internal
PEG10 promoter appears responsible for imprinted regulation
of both genes, despite the hypomethylation reaching into SGCE
in all methylomes. One plausible scenario is that regulatory ele-
ments within the AMR interact with those nearby in the hypo-
methylated portion of the CGI to regulate SGCE.
Discussion
We presented a computational strategy for identifying ASM in
methylomes produced by BS-seq technology. Our method does
not depend on the existence of genotypic variation and is there-
fore able to identify ASM associated solely with parent-of-origin.
Results on simulated data indicate that our method has generally
high specificity, and that sensitivity increases with read length
as well as mean coverage throughout the genome. Our results
also show that this model is accurate even for current read lengths
and depths of coverage, both of which are critical technical para-
meters in connecting methylation states of individual molecules.
We applied our method to 22 publicly available human methy-
lomes and validated its accuracy on real data by comparing ASM
identified on female and male X chromosomes. Our most con-
sistent predictions across methylomes showed high concordance
with known AMRs associated with imprinted genes. The remain-
ing predictions represent likely candidate ICRs for imprinted
loci, with several overlapping lncRNA promoters and supported
by similar analysis at orthologous regions based on low-coverage
methylomes from chimp.
Our top predicted autosomal AMRs show remarkable concor-
dance with known AMRs controlling imprinted gene expression.
Among the 39 common to all uncultured methylomes and prox-
Table 2. Imprinted clusters and associated AMRs
Cluster Known ICR Unc ESC iPSC Tot Chimp
GNAS Y Y 5 4 5 22 3
SGCE/PEG10 Y Y 5 4 5 22 3
MESTIT1/MEST Y Y 5 4 5 22 3
ZNF597/NAA60 Y Y 5 4 5 22 2
SNRPN/SNURF Y Y 5 4 5 22 1
AMPD3 5 4 5 22 0
NAP1L5 Y Y 5 4 5 21 3
KCNQ1OT1 Y Y 5 3 5 21 0
PSIMCT-1/HM13 Y Y 5 2 5 20 3
KCNK9 Y Y 5 3 4 20 3
INS-IGF2-H19 Y Y 5 2 5 20 0
DIRAS3 Y Y 5 2 5 19 3
ZDBF2 Y Y 5 3 4 19 2
FANK1 Y 5 2 5 18 0
BLCAP/NNAT Y Y 5 2 2 14 2
ZIM2/PEG3 Y Y 5 1 0 12 0
DLK1/MEG3 Y 5 0 0 11 3
RB1 Y Y 5 0 0 7 3
L3MBTL Y Y 4 3 5 19 3
DDC/GRB10 Y Y 4 3 4 19 3
PLAGL1/HYMAI Y Y 4 2 4 18 3
FAM50B Y Y 4 0 1 12 3
TCEB3C Y Y 4 1 1 11 0
INPP5F Y Y 3 3 5 18 2
IGF2R Y 2 0 4 13 1
DXLGAP2 1 1 0 2 0
TP73 1 0 0 1 0
ANKRD11 1 0 0 1 0
DLX5 0 0 0 2 0
ABCA1 0 0 0 1 0
WT1 0 0 0 0 0
RBP5 0 0 0 0 0
Columns indicate whether the AMR was previously known, an ICR, and the
number of uncultured (Unc), ESCs, iPSCs, total (Tot), and chimp methylomes
in which each AMR was found. Genomic locations of AMRs can be found in
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Fig. 3. Regions of allele-specific methylation through (A) the GNAS and (B) SGCE/PEG10 loci in five uncultured blood cells (HSPC, neutrophils, B cells, and CD
133+ cord blood cells). Vertical orange bars indicate methylation levels of CpGs. In both examples refined AMRs show highly consistent boundaries across
methylomes, and each includes an AMR with a precise boundary inside a CGI, distinguishing the regulatory regions of distinct TSS.
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imal to annotated promoters, 18 are marking known imprinted
genes. It appears as though the AMRs that are already known
are also those identified most consistently across methylomes.
This finding can be interpreted in several ways. One possibility
is that a significant portion of the imprinted genes or clusters,
possibly more than half, have already been identified. Estimates
of the total number of imprinted genes in human hover around
100–200 (39, 40), and many parent-of-origin disease phenotypes
have already been explained through known imprinted genes.
Among our remaining predictions (several hundred putative
AMRs) many could represent weaker ASM signals possibly with-
out functional relevance, and these are identified with less con-
sistency across datasets because of a lack of sensitivity in our
method. Another possibility is that many genes are imprinted
with cell-type specificity, and that the known AMRs are biased
toward those that can be identified in a greater variety of cell
types. Our top predictions were based on consistency across
the available methylomes from uncultured cells, but these all hap-
pened to be from blood.
Another important finding to emerge from our analyses is the
precision with which AMRs are defined across cell types. The
GNAS and SGCE/PEG10 examples illustrate this strong consis-
tency of AMR boundaries: In both of these examples, there are
pairs of TSS in very close proximity, sharing CGIs, but for which
one has ASM methylation and the other does not. Methods like
ours that can delineate the boundaries of AMRs will assist future
efforts to precisely map the elements inside these regulatory regions.
Among the 22 methylomes analyzed, the total number of iden-
tified AMRs varied substantially across methylomes. Much of this
variation is likely due to variation in coverage and number of
CpGs/read, and relates to sensitivity as illustrated in our simula-
tions. A substantial part may also be due to epigenotypic variation
between the cells: Those from culture will exhibit the associated
epigenomic effects. It has been known for some time that perma-
nent cell lines have altered DNA methylation (41, 42), and more
recently it was shown that aberrant methylation is correlated with
passage number (43). We also observed some examples which
might indicate an effect of culture conditions, such as the MEG3
AMRs (Fig. S4) where cells differentiated in culture show differ-
ent properties from other somatic cells. Moreover, any methy-
lome datasets derived from single individuals might exhibit the
effects of genotype (44).
Combining experimental approaches with analytic methods
such as ours on appropriate biological samples will reveal the
breadth of cell-type specific ASM in humans and further clarify
the mechanisms underlying imprinted gene expression in human
diseases. Moreover, conducting similar studies in appropriately
selected mammalian species will help to elucidate the enigmatic
role of sexual conflict influencing mammalian evolution.
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